Two Sigma Investments, LP Kal Vista Pharmaceuticals, Inc. Transaction History
Two Sigma Investments, LP
- $42.3 Billion
- Q3 2024
A detailed history of Two Sigma Investments, LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 26,950 shares of KALV stock, worth $264,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,950
Previous 28,197
4.42%
Holding current value
$264,110
Previous $332,000
6.02%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding KALV
# of Institutions
124Shares Held
47.8MCall Options Held
51.9KPut Options Held
110K-
Vr Adviser, LLC New York, NY6.25MShares$61.2 Million7.5% of portfolio
-
Tang Capital Management LLC San Diego, CA4.32MShares$42.4 Million4.26% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.21MShares$41.3 Million1.92% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$39.2 Million3.51% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$36.1 Million2.3% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $241M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...